摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(6-tert-butyl-3,4-dihydro-2H-quinolin-1-yl)ethanone

中文名称
——
中文别名
——
英文名称
1-(6-tert-butyl-3,4-dihydro-2H-quinolin-1-yl)ethanone
英文别名
——
1-(6-tert-butyl-3,4-dihydro-2H-quinolin-1-yl)ethanone化学式
CAS
——
化学式
C15H21NO
mdl
——
分子量
231.33
InChiKey
JZXRHURLHHQDOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • Therapeutic compounds and uses thereof
    申请人:GENENTECH, INC.
    公开号:US10696655B2
    公开(公告)日:2020-06-30
    The present invention relates to compounds of formula (I) and formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R5-R6 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II), or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
    本发明涉及式(I)和式(II)化合物: 及其盐,其中式(I)的 R1-R4 和式(II)的 R5-R6 具有本文定义的任一值,以及其组合物和用途。这些化合物可用作 CBP 和/或 EP300 的抑制剂。还包括包含式(I)的式(II)的化合物或其药学上可接受的盐的药物组合物,以及使用这种化合物和盐治疗各种CBP和/或EP300介导的疾病的方法。
  • THERAPEUTIC COMPOUNDS AND USES THEREOF
    申请人:GENENTECH, INC.
    公开号:US20190152949A1
    公开(公告)日:2019-05-23
    The present invention relates to compounds of formula (I) and formula (II): and to salts thereof, wherein R 1 -R 4 of formula (I) and R 5 -R 6 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II), or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
查看更多